The amino acid sequence of caveolin-1 predicts that it is an integral membrane protein and there is strong experimental evidence that it has this property. For example, caveolin-1 is co-translationally inserted into the ER and shipped to the Golgi apparatus where it is incorporated into lipid domains that sort molecules for shipment to the cell surface (1) . The preferred location for caveolin-1 at the cell surface is the caveola, and it cannot be removed from these membranes without detergent (2) . Finally, the movements of GFP-tagged caveolin-1 suggest that normally caveolin-1 moves with caveolae-derived vesicles to multiple interior compartments and then recycles back to the cell surface (3).
By contrast, there is compelling evidence that caveolin-1 can be a soluble protein. Immunogold labeling first detected soluble caveolin-1 in the lumen of the ER after cells were exposed to cholesterol oxidase (4) . Then a small pool of soluble caveolin-1 was found in fibroblast cytosol, in a complex with chaperones (5) . A routine survey of caveolin-1 distribution in different tissues identified cells that targeted caveolin-1 primarily to the cytosol (skeletal muscle cells and keratinocytes), to the lumen of secretory vesicles (serous cells of pancreas, fundic stomach and salivary gland) and to mitochondria (airway epithelial cells and hepatocytes) (6, 7) . Both the secreted and the cytosolic caveolin-1 appear to be embedded in lipoprotein-like particles, which may explain why they are soluble.
Thus, caveolin-1 is an unusual protein that can be both an integral membrane protein and soluble in multiple cellular compartments. We believe this property is an important clue about its function.
CAVEOLIN-1 AND CAVEOLAE
Caveolin-1 (VIP21) was first identified as a tyrosine phosphorylated protein in Rouse sarcoma transformed cells (8) that was enriched in both caveolae (2) and vesicles targeted to the apical surface of polarized epithelial cells (9) . Caveolae (plasmalemmal vesicles) were first identified in 1953-55 as endocytic structures that transport molecules across endothelial cells (10) . Typically caveolae are recognized in thin section EM images by their flask-shaped morphology. The cytosolic surface of each caveola, however, has a striated coat (2) that is best seen in rapid-freeze deep-etch images. Caveolin-1 has been localized to the filaments that make up this coat. Caveolin-1 readily oligomerizes in vitro (1) , and recent structural studies indicate the N-terminal 101 amino acids assemble into heptameric subunits that appear to be the basic building block of each filament (11) . The characteristics of other membrane coats, such as clathrin, COPI, and COPII, led to the expectation that caveolin was necessary for caveolae budding.
Indeed, rapid-freeze deep-etch images showed caveolin-1 coats decorating membranes in different stages of membrane invagination, and cells lacking caveolin-1 appear not to have flask-shaped membranes (12) . Recent studies, however, call in to question whether caveolin-1 is needed for internalization and traffic of caveolae (see below).
There are three caveolin genes expressed in mammals (designated caveolin-1, 2 and 3) and they code for five different isoforms of the protein (1) . Most tissues in the body express at least one of these isoforms. Notably lacking are cultured lymphocytes and certain neuronal cells. Caveolin-1 and 2 are usually coexpressed and assemble into hetero-oligomers in the ER and Golgi apparatus (13) .
These oligomers mature into higher molecular weight complexes once they reach caveolae. Interestingly, caveolin-2 appears unable to exit the Golgi apparatus by itself (14) and is rapidly degraded in cells not expressing caveolin-1. In skeletal and heart muscle cells, caveolin-3 replaces caveolin-1 in caveolae. Skeletal muscle cells selectively express the β isoform of caveolin-1, but it is targeted to the cytosol where it tends to collect along the Z-line (6).
CAVEOLIN-1 FUNCTIONS
One way to understand the function of a protein is to identify its interacting partners. A variety of proteins have been identified that interact with either caveolin-1 or tyrosine phosphorylated caveolin-1 (pY14). In addition, caveolin-1 interacts with both lipids and lipid anchors on proteins (Table 1 ). These interactions predict that caveolin-1 functions in lipid traffic, membrane traffic and signal transduction.
A role in lipid transport
Cholesterol is required for the structure (2) and function of caveolae (15) . In vitro assays have shown that caveolin-1 interacts with cholesterol (16) , suggesting that it may organize membrane cholesterol in caveolae. Caveolin-1 also binds with high affinity long chain unsaturated fatty acids (17) , which may account for its ability to interact with the GM1 gangliosides (18) that collect in caveolae. A strong argument can be made, however, that caveolin-1 plays a role in the import and export of cellular cholesterol by caveolae.
The first indication caveolae were involved in cholesterol traffic came from the observation that in normal human fibroblasts cholesterol moves directly to surface caveolae within minutes after being synthesized in the ER (19) . From caveolae the cholesterol then moves rapidly to other regions of the plasma membrane and to the extracellular space. The rapid transport of new cholesterol to the lymphocyte cell surface is dependent on the expression of caveolin-1 (19) .
Non-palmitoylated caveolin-1 is impaired in the transport of new cholesterol in these cells (20) . ER to plasma membrane transport of new cholesterol is also inhibited by progesterone, and this steroid causes caveolin-1 to accumulate in internal membranes (1) . Finally, expression of a truncated caveolin-3 (Cav  DGV ) dramatically lowers the cholesterol content of caveolae in CV1 cells, which can be reversed by the addition of exogenous cholesterol (21) . The mechanism of action of Cav DGV is not known, although it is presumed that it interferes with caveolin-1 function.
Plasma membrane cholesterol can move directly to the ER (22) . Free cholesterol, cholesterol esters, and cholesterol ethers in HDL bound to SR-B1 can also move to intracellular sites from caveolae (23) . Expression of caveolin has been linked to cholesterol import (24) , but the rapid migration of caveolin to the ER after the oxidation of caveolae cholesterol (4) suggests it has a direct role in cholesterol import. The mystery is how can caveolin-1, which is an integral membrane protein in caveolae, carry cholesterol to intracellular compartments like the ER?
A solution to this puzzle may be cytosolic caveolin-1. Several laboratories have verified the initial discovery (5) that the cytosol of many cells contains a pool of soluble caveolin-1. This caveolin-1 is associated with cholesterol and behaves like a protein that is embedded in a particle with the size (25) and buoyant density (6) of HDL. Cholesterol esters that enter cells through caveolae appear to associate with cytosolic caveolin-1. Likewise, the same particle may also carry new cholesterol from the ER to the plasma membrane (23) . Recently it has been found that apoA-1 binding to SR-B1 stimulates the formation of cytosolic lipid particles containing caveolin-1, cholesterol and phospholipid (25) . Importantly, caveolin-1 is secreted by exocrine secretory cells in HDL particles containing apoA-1, raising the possibility that caveolin-rich lipid particles in the cytoplasm are involved in the assembly of secreted lipoproteins. Soluble cytoplasmic caveolin particles may also be important for the biogenesis of cytoplasmic lipid droplets (26) .
In summary, caveolin-1 has a function in intracellular and extracellular lipid transport. This function may account for the high level of caveolin-1 expression in adipocytes (6) as well as the apparent abnormalities in lipid metabolism that are seen in caveolin-1 null mice (27) . Caveolin-1 is not behaving like a simple lipid carrier protein but, instead, seems to be part of a novel intracellular lipid particle that transports lipids between organelles similar to the way that plasma lipoproteins move lipids between tissues. The precise lipid and protein composition of this particle remains to be determined.
A role in membrane traffic
The principle site where one would expect caveolin-1 to function in membrane traffic is at the caveola. Caveolae are well known for their unique endocytic properties (reviewed in (10)). Caveolin-1 could attract proteins to caveolae the same way that clathrin adaptors attract transmembrane receptors to coated pits, and/or function as a molecular motor that powers membrane invagination and budding. There is very little evidence, however, that caveolin-1 functions this way. Caveolin-1 has been reported to interact with several receptor tyrosine kinases (see Table 1 ), including the EGF receptor (EGFR). The information for EGFR localization to caveolae/rafts, however, is in the extracellular domain of the receptor (28) , so an interaction with caveolin-1 probably has nothing to do with EGFR attraction to caveolae. A recent study also challenges the assumption that caveolin-1 is required for caveolae internalization. Receptor mediated uptake of autocrine motility factor (AMF) normally occurs by both coated pit and caveolae pathways (29) . The caveolae path delivers the factor directly to the ER while coated pits deliver it to endosomes.
Delivery to the ER, however, appears to occur in cells deficient in caveolin-1. This study did not determine, however, whether the defect was due to malfunctioning caveolae or the absence of the albumin receptor GP60 at the cell surface.
If the studies on AMF uptake are confirmed, then caveolin-1 must be a negative regulator of caveolae membrane internalization and traffic. How could this be? A regulatory rather than structural function for caveolin-1 actually agrees very nicely with several recent observations on the movement of membrane populations containing caveolin-GFP (3). This probe has become an invaluable tool for studying the movement of caveolae and caveolae-derived membranes.
Surprisingly, most caveolae on the surface of cells are immobile and not traveling to interior sites of the cell (3). Caveolae internalization is tightly regulated by PKC and tyrosine kinases (10) . Pathogens like SV40 virus can commandeer this regulatory system and stimulate their own internalization through caveolae by activating an unknown tyrosine kinase (32) . Caveolae tend to collect in actin-rich regions of the cell membrane and they contain a number of actin binding proteins.
One is filamin, which may interact directly with caveolin-1 (Table 1) . Therefore, an important function of caveolin-1 may be to regulate the interaction of caveolae with the cortical actin cytoskeleton, thereby controlling whether caveolae are at the cell surface or traveling to interior sites. This interaction, in turn, may be controlled by tyrosine phosphorylation of caveolin-1.
A role in signal transduction
Immediately following the identification of caveolin-1 as a caveolae marker protein, procedures were developed for isolating caveolae from tissues as well as tissue culture cells (10) . An unanticipated outcome of using these isolation procedures was the discovery that caveolae are rich in multiple molecules that function in cellular signal transduction (10) . The ability to rapidly isolate these membrane domains led to the discovery that many signaling molecules are dynamically associated with caveolae. For example, quiescent fibroblasts have very little Raf-1 in caveolae but are enriched in EGFR.
After EGF binds EGFR, Raf-1 is recruited to caveolae at the same time as EGFR moves to non-caveolae membranes (33) . Entire signaling modules like the PDGFR-Ras-ERK module have been localized to caveolae, and they are fully functional even after caveolae are isolated away from the cell (34) . In light of these discoveries, it was only natural to think that caveolin-1 modulated signal transduction by attracting signaling molecules to caveolae and regulating their activity.
A scaffolding function for caveolin-1 arose out of a consideration of the propensity of this molecule to oligomerize (35) . Purified caveolin-1 spontaneously forms oligomers in solution and oligomerization maps to a region of the molecule between amino acid 80 and 101, which is on the N-terminal side of the putative membrane insertion region (36) . An ability to polymerize fits well with the idea that caveolin-1 is a structural component of the filamentous caveolae coat. Li et al (37) were the first to show that a synthetic peptide matching the amino acid sequence between residues 80-101 in caveolin-1 inhibited Src kinase activity.
Moreover, a GST fusion protein containing amino acids 61-101 of caveolin-1 preferentially interacts with inactive Src. The sequence between 80-101 was named the caveolin-1 scaffolding domain (37) . Subsequently a synthetic scaffolding domain peptide was used to isolate two binding motifs from a phage display library with the sequences ΦxΦxxxΦ and ΦxxxxΦxΦ where Φ is aromatic (38) . Many, but not all, caveolin-1 interacting proteins contain one of these sequences (reviewed in (1)).
A key part of the caveolin-1 scaffolding domain hypothesis is the proposal that it functions to inactivate signaling molecules (39) . Many studies have documented an interaction between the caveolin-1 scaffolding domain and various signaling molecules (see Table 1 for a partial list). Although these interactions often suppress the signaling activity of the molecule as predicted (1), in some cases the scaffolding domain stimulates activity (40) or has no affect at all (41).
The most common assay used in these studies measures the effect of the scaffolding peptide (verses a scrambled peptide sequence) on signaling activity in vitro. Recently, however, this peptide has been found to inhibit eNOS activity 
THE INTRACELLULAR ITINERARY OF CAVEOLIN-1
Caveolin-1 appears to have principle functions in lipid transport, membrane traffic and cell signaling. The mechanistic basis of these functions remains to be worked out but must be reflected in the complex and mysterious intracellular traffic of this protein. A model is proposed in Figure 1 for how we think caveolin-1 might move from its site of synthesis to various compartments in the cell.
Caveolin-1 appears to be inserted co-translationally into the ER membrane with its N-terminal and C-terminal portions in the cytoplasm (red path, Fig 1) . It then is incorporated into vesicles (1, Fig 1) that move to the Golgi apparatus in a step that requires amino acids 66-70 (IDFED) (44) . Within the Golgi apparatus caveolin-1 oligomerizes and becomes detergent insoluble (47) . Oligomerization depends on amino acids 91-100 (TFTVTKYWFY) and 135-140 (KSFLIE). Vesicular transport to the cell surface (2, Fig 1) depends both on the ability of the molecule to oligomerize and on amino acids 71-80 (VIAEPEGTHS). Once it reaches the cell surface, presumably caveolin-1 becomes incorporated into functioning caveolae that internalize and recycle (3, Fig 1) . At some stage in the caveolae internalization cycle, we believe caveolin-1 can enter the cytoplasm of the cell as a soluble protein embedded in a lipid particle (4-6, Fig 1) . The exact amino acids in the protein that control this step are not known, but may depend on palmitoylation of cysteines 133, 143 & 156 (20) . There are multiple targets for the soluble caveolin-1. It may go to the ER (4, Fig 1) and either pickup newly synthesized cholesterol for transport back to caveolae (return blue arrow) or enter the lumen of the ER. If the latter occurs, then the soluble caveolin-1 (blue path, Fig 1) is incorporated in to HDL-like particles that are secreted by the cell (7). Another possibility is that the soluble caveolin-1 remains in the cytosol (green, Fig 1) .
Some of this caveolin-1 may be targeted to lipid droplets (26) . Finally, soluble caveolin-1 can go to mitochondria (orange, Fig 1) . Nothing is known about how the distribution of caveolin-1 is regulated or the machinery responsible for converting caveolin-1 from a membrane to a soluble protein. Figure 1 Intracellular itinerary of caveolin-1. The description of the pathway is in the last paragraph of the text. Table 1 A partial list of proteins and lipids that interact with caveolin-1. IP, immunoprecipitation; GST, glutathione-S-transferase fusion protein pull down; pY, tyrosine phosphorylation.
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